[Rifampicin as a standard constituent of antituberculous drug therapy?].
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use*; D000637:Transaminases / Q000378:metabolism; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D000637:Transaminases; D012293:Rifampin
Standardkombinationsbehandlung mit Rifampicin.